IRTC Q3 2022 Earnings — iRhythm Technologies, Inc. Revenue & Financial Results | Market Cap Arena

IRTCiRhythm Technologies, Inc.

$4B

Q3 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$104M+21.6% YoY

Gross Profit

$71M68.3% margin

Operating Income

-$21M-20.3% margin

Net Income

-$21M-20.7% margin

EPS (Diluted)

$-0.71

QoQ Revenue Growth

+1.8%

Cash Flow

Operating Cash Flow

$4M

Free Cash Flow

-$3M

Stock-Based Comp.

$13M

Balance Sheet

Total Assets

$440M

Total Liabilities

$201M

Stockholders' Equity

$239M

Cash & Equivalents

$71M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$104M	$85M	+21.6%
Gross Profit	$71M	$56M	+26.3%
Operating Income	-$21M	-$23M	+9.4%
Net Income	-$21M	-$24M	+9.6%

Revenue Segments

Commercial Payors

$56M73%

Healthcare Institutions

$15M19%

Non-Contracted Third-Party Payors

$6M7%